Item 9 Labs Corp (INLB)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 23, 10:56
Item 9 Labs Cash from Financing (Quarterly): -0.005M for June 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.005M |
| March 31, 2023 | -0.2247M |
| December 31, 2022 | 1.278M |
| September 30, 2022 | 1.273M |
| June 30, 2022 | 2.484M |
| March 31, 2022 | 1.876M |
| December 31, 2021 | 0.4131M |
| September 30, 2021 | 0.3359M |
| June 30, 2021 | -0.0895M |
| March 31, 2021 | 6.379M |
| December 31, 2020 | 4.652M |
| September 30, 2020 | -0.3613M |
| June 30, 2020 | 0.8303M |
| March 31, 2020 | 0.60M |
| December 31, 2019 | 0.469M |
| September 30, 2019 | 2.277M |
| June 30, 2019 | 1.46M |
| March 31, 2019 | 2.25M |
| December 31, 2018 | 3.15M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.4216M |
| March 31, 2018 | 1.09M |
| December 31, 2017 | |
| September 30, 2017 | -0.005M |
| June 30, 2017 | -0.0038M |
| Date | Value |
|---|---|
| March 31, 2017 | 0.00 |
| December 31, 2016 | |
| September 30, 2016 | 0.0969M |
| June 30, 2016 | -0.0119M |
| March 31, 2016 | 0.1971M |
| December 31, 2015 | 0.0425M |
| September 30, 2015 | 0.2026M |
| June 30, 2015 | 0.1848M |
| March 31, 2015 | 0.1211M |
| December 31, 2014 | 0.2382M |
| September 30, 2014 | 0.1638M |
| June 30, 2014 | 0.2385M |
| March 31, 2014 | 0.0886M |
| December 31, 2013 | 0.2864M |
| September 30, 2013 | 0.0208M |
| June 30, 2013 | 0.1245M |
| March 31, 2013 | 0.3425M |
| December 31, 2012 | -0.0801M |
| June 30, 2012 | 0.075M |
| March 31, 2012 | 0.305M |
| December 31, 2011 | 0.0328M |
| September 30, 2011 | -0.5712M |
| June 30, 2011 | 0.445M |
| March 31, 2011 | 0.1335M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.3613M
Minimum
Sep 2020
6.379M
Maximum
Mar 2021
1.391M
Average
0.8303M
Median
Jun 2020
Cash from Financing (Quarterly) Benchmarks
| Humanigen Inc | 0.00 |
| Cannabis Global Inc | -0.156M |
| Cantabio Pharmaceuticals Inc | 0.52M |
| Affymax Inc | -- |
| Statera BioPharma Inc | 0.7117M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.1501M |
| Cash from Investing (Quarterly) | -0.0628M |
| Free Cash Flow | -2.597M |
| Free Cash Flow Per Share (Quarterly) | 0.0009 |
| Free Cash Flow to Equity (Quarterly) | -0.8776M |
| Free Cash Flow to Firm (Quarterly) | 3.037M |